English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1996]
News [3249]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression
EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease...
EHA 2015:  A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia
EHA 2015: A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia
EHA 2015: Treatment and survival of patients with chronic myeloid leukemia (CML) in Europe
EHA 2015: Treatment and survival of patients with chronic myeloid leukemia (CML) in Europe
EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?
EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?
Cytotoxic T-cells captured on film destroying cancer cells
Cytotoxic T-cells captured on film destroying cancer cells
Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma
Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma
ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s
ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s
ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia
ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia
Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia
Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia
Circulating tumour DNA in blood predicts recurrence of common lymphoma type
Circulating tumour DNA in blood predicts recurrence of common lymphoma type
<1...206207208209210...325>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top